Marksans Pharma Launches Omeprazole Tablets

  Published 8 months ago

Marksans Pharma introduced bioequivalent Omeprazole 20 mg tablets, matching Prilosec OTC, for heartburn and acid-related disorder treatment.

  • Omeprazole is a proton pump inhibitor effective in treating GERD, dyspepsia, and heartburn by reducing excess stomach acid.
  • Product matches reference drug Prilosec OTC 20 mg, marketed by AstraZeneca under NDA 021229, ensuring equivalent efficacy and safety.
  • Marksans operates globally with USFDA, UKMHRA, and TGA-approved facilities, offering a diversified portfolio across multiple therapeutic segments.

You might like these

Lemon Tree Hotels’ Record Q1 Surge

Oberoi Realty Q1 PBT Falls 35%

DÉKUPLE China: Bridging Europe & China

Indian Gold Futures Hit Record 100K Rupees per 10g

Biocon Eyes Generic Wegovy Launch

Supreme Wins Rs 54 Cr BPCL Deal

HLE Glascoat Acquires Omeras, Expands Tank Market

News that matters the most ⚡